Two surveys of pharmaceutical executives released Tuesday suggest a troubling, or at least tumultuous, future for an industry that employs thousands of people in the Philadelphia area. The consulting firm KPMG spoke with 100 senior executives from companies in three annual-revenue categories, though none with less than $100 million.
